![3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine Kiʻi Hōʻike ʻia](http://cdn.globalso.com/hengkangpharma/1657269157159.png)
3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine
ʻO ka wehewehe pōkole:
CAS: 1022150-12-4
MF: C22H22N6O
MW: 386.45
EINECS: 200-001-8
Nā Māhele Huahana: Ibrutinib;Nā mea waena
Nā huaʻōlelo like
2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-methyl-3-(4-methyl-1-piperazinyl)
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
3-(4-phenoxyphenyl)-1-(3R)-3-piperidinyl-1H-Pyrazolo[3,4-d]pyrimidin-4-amine
3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine
Ibrutinib intermeidate N-1
(R)-3-(4-FLUOROPHENYL)BUTANOIC ACID
ibrutinib N-1
(R)-3-(p-fluorophenyl)butanoic acid
Ibrutinib (PCI-32765) Kūwaena
Btk inhibitor 1 (R enantioMer)
Na Waiwai Kemika
Puni paila: 626.3±55.0 °C(Wānana ʻia)
Māmā: 1.39±0.1 g/cm3 (Wānana ʻia)
ka mahana mālama: E mālama i kahi pōʻeleʻele, Inert ea, 2-8 ° C
pka: 9.00 ± 0.10(Wanamua)
ʻIke pilikia
1 Ka hoʻokaʻawale ʻana o ka mea a i ʻole ka hui ʻana
ʻaʻohe ʻikepili i loaʻa
2 mau mea lepili GHS, me nā ʻōlelo hoʻomalu
| Piktogram(mau) | ʻaʻohe ʻikepili i loaʻa |
| ʻŌlelo hōʻailona | ʻaʻohe ʻikepili i loaʻa |
| ʻŌlelo (mau) pōʻino | ʻaʻohe ʻikepili i loaʻa |
| ʻŌlelo kiaʻi | |
| Kāohi | ʻaʻohe ʻikepili i loaʻa |
| Pane | ʻaʻohe ʻikepili i loaʻa |
| Waihona | ʻaʻohe ʻikepili i loaʻa |
| Holoi | ʻaʻohe ʻikepili i loaʻa |
3 Nā pōʻino ʻē aʻe i hopena ʻole i ka hoʻokaʻawale ʻana
ʻaʻohe ʻikepili i loaʻa
Nā ʻōlelo kikoʻī
Pkino kino: paʻa keʻokeʻo i ka melemele
ʻIkepili (Na HPLC)：Kūlike
Pmimi (e HPLC): 97%
Wai (KF):≤0.5%
Smahana hipping: lumi wela
Cʻāina kumu: Kina
ʻO kā mākou pono
1 Hana ʻia kā mākou huahana i ka mea kanu i hoʻolaʻa ʻia ʻo ISO9001: 2015 Certified.
2E pane ʻia kāu nīnau i loko o 24 mau hola.ʻAʻohe ʻokoʻa kai hoʻomaha.
3Hiki iā ʻoe ke noi i kahi huakaʻi wikiō ma kā mākou hale hana.
4Hiki ke hoʻolālā ʻia ka maikaʻi o ka huahana e like me kāu mau koi.
ʻO kā mākou pono
1: Ua ʻike kā mākou hale hana i ka ʻoihana kūʻai nui mai ka makahiki 2012, ʻoi aku ka nui o nā kūʻai makahiki ma mua o 20tons.
2 ʻO ia ka mea hoʻolako kūpono no ka hui lāʻau patent o Ibrutinib.
3 ʻOi aku ka maikaʻi o ka huahana: Assay: 97.0%-103.0%
Maʻemaʻe kemika (wahi GC): ﹦ 99.0%
ʻO nā mea haumia ʻole i hōʻike ʻia﹤ ﹦ 0.08%
ʻO ka maʻemaʻe chiral (wahi HPLC): ﹥ ﹦ 99.5%
4 Hana ʻia ia e ke ʻano hoʻonā Kemika.
5 Ua hōʻoia ʻia nā ʻano hoʻāʻo a pau.
6 Hoʻokahi hale hana hoʻolaʻa no ka hana ʻana.
![4-Aminopyrazolo [3,4-d] pyrimidine](http://cdn.globalso.com/hengkangpharma/1657268921238-300x300.png)
![3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-amine](http://cdn.globalso.com/hengkangpharma/1657265362012-300x300.png)
